Gadovist and nephrogenic systemic fibrosis Patient Reports February 10, 2012

Gadovist Side Effects Report #5425774-2
Gadovist side effect was reported by a Physician from SWITZERLAND on July 26, 2007. Female patient, weighting 131.2 lb, was diagnosed with angiogram and was treated with Gadovist. After drug was administered, patient experienced the following side effects: nephrogenic systemic fibrosis. Gadovist dosage: 15 ML, 1 DOSE. During the same period patient was treated with DOTAREM, IOPAMIRO. Patient was hospitalized. Patient recovered.